Navigation Links
Haemacure Reports Third Quarter 2007 Results
Date:8/31/2007

of this sum. This has no impact on Haemacure's current financial situation.

About Haemacure

Haemacure Corporation is a specialty bio-therapeutics company developing high-value human therapeutic proteins for commercialization. Haemacure's research and development effort is driven by its proprietary plasma protein extraction technology to develop next-generation products, including surgical hemostats.

Haemacure's lead product candidate, Hemaseel(R)HMN, is a human-derived fibrin sealant in late-stage clinical development. Haemacure's second product candidate is human thrombin, a component of its fibrin sealant. Both candidates have applications in the expanding bio-surgical market. Follow-on development will focus on surgical hemostats, bio-material combinations and drug delivery in select therapeutic areas. Haemacure has recently discovered additional specialty proteins in its plasma-derived intermediates and will advance these specialty proteins through partnerships with pharmaceutical and biotechnology companies.

Forward-looking Statements

Certain of the statements contained in this news release may be forward-looking statements. Such statements, based as they are on the current expectations of management, inherently involve numerous risks and uncertainties, known and unknown. Some examples of known risks include, but are not limited to the following: the impact of general economic conditions, general conditions in the biotech industry, results and outcomes of Haemacure's clinical trials, changes in the regulatory environment in the jurisdictions in which Haemacure Corporation does business, stock market volatility, fluctuations in costs, and changes to the competitive environment due to consolidation or otherwise. Consequently, actual future results may differ materially from the anticipated results expressed in the forward-looking statements. Haemacure Corporation disclaims any intention or obligation to update these statements.

'/>"/>
SOURCE HAEMACURE CORPORATION
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Autopsy reports could be valuable and informative
2. China reports declining number of SARS Cases
3. Russia Reports First SARS Case
4. Research reports that c-section deliveries are rising
5. Jharkhand reports 13,000 Malaria cases
6. Uganda Reports Failure To Contain Sleeping Sickness
7. WHO reports 36 million deaths world wide due to chronic diseases
8. Reports of Hantavirus infection in India raise concerns
9. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
10. China Reports Yet Another Bird Flu Case
11. China reports seventh bird flu victim
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Mitul R. Patel, DDS and concerned ... MGE Management Experts Benefit Dinner May 30, in St. ... Dentists to raise funds for the Improving Youth Literacy ... and Youth Programs across America. The funds raised are ... and audio books to directly tackle illiteracy and help ...
(Date:7/28/2014)... Dr. Alan Xenakis, MD announced today the release ... The new book, DOC X MD Funny Feelings ... telling style with humor and medical accuracy. The book is ... find answers to those age-old questions that most folks are ... Why do mosquitoes bite some and not others? Why do ...
(Date:7/27/2014)... the leader in compression technology and sports medicine, has expanded ... The wrist support features an adjustable velcro strap and provides ... more commonly referred to as tennis elbow and golfers elbow, ... tendons attached to the outside of the elbow. Although this ... the wrist and fingers turn into a tendon that attaches ...
(Date:7/27/2014)... Manufacturers of natural ingredient beauty creams are ... a younger appearance. The Cherry News company has published ... and women explore the availabilities from U.S. retailers at ... in the posted guide on the Cherry News website ... drawback to some natural ingredient formulas is the high ...
(Date:7/27/2014)... of hepatitis E virus (HEV) transmission by blood components ... have HEV in their plasma. The findings, published in ... blood components (eg, red cells, platelets, and fresh frozen ... England. , The study retrospectively screened 225 000 ... Oct, 2012 and Sept, 2013 for HEV RNA. 79 ...
Breaking Medicine News(10 mins):Health News:Mitul R. Patel, DDS Successfully Attacks a Major Source of Economic Destruction in the Battle Against Illiteracy and Poverty 2Health News:Mitul R. Patel, DDS Successfully Attacks a Major Source of Economic Destruction in the Battle Against Illiteracy and Poverty 3Health News:New Book by Alan P. Xenakis, MD Reveals Mind and Body Mysteries 2Health News:Zensah® Releases New Wrist Support 2Health News:Natural Eye Cream Buyer's Guide Published Online at Consumer News Website 2Health News:The Lancet: 1 in 3000 blood donors in England infected with hepatitis E 2
... Roughly 15% of children suffer from migraines, and approximately one-third ... of symptoms that can include weakness, blind spots, and even ... new study soon to be published in The Journal ... children and a heart defect called patent foramen ovale, which ...
... cells in the intestine, which when they mutate can lead ... to combat the effects of those same cancers, the UK ... today. Professor Nick Barker of the Institute of Medical ... identified that the stem cells which are crucial to maintaining ...
... Commons, an initiative of CollabRx, a provider of ... research, announces the publication of a molecular disease ... into molecular subtypes, rather than traditional histological or ... subtype, including specific assays, drugs, and clinical trials. ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, March ... U.S. Food and Drug Administration (FDA) is meeting Wednesday and ... used food dyes and attention-deficit/hyperactivity disorder (ADHD), and if so, ... industry against some parents, public watchdog groups and academics who,ve ...
... HealthDay Reporter , WEDNESDAY, March 30 (HealthDay News) -- ... nursing homes, a new study shows. Researchers say the ... lead to improvements in patient care. Nor does it appear ... in terms of fewer lawsuits. "Nursing homes that are ...
... for Maternal-Fetal Medicine (SMFM) weighed in on today,s FDA ... caproate, also known as 17P. This FDA announcement ... and others regarding the costs of the just-released pharmaceutical ... made by KV Pharmaceuticals, is being sold at $1,500 ...
Cached Medicine News:Health News:Attacking bowel cancer on 2 fronts 2Health News:Researchers publish molecular disease model for melanoma 2Health News:Researchers publish molecular disease model for melanoma 3Health News:FDA Panel Examines Possible Links Between Food Dyes, ADHD 2Health News:FDA Panel Examines Possible Links Between Food Dyes, ADHD 3Health News:FDA Panel Examines Possible Links Between Food Dyes, ADHD 4Health News:Lawsuits Aren't Improving Nursing Home Care: Study 2Health News:Lawsuits Aren't Improving Nursing Home Care: Study 3Health News:Lawsuits Aren't Improving Nursing Home Care: Study 4Health News:Society for Maternal-Fetal Medicine commends FDA on makena announcement 2
(Date:7/28/2014)... ANGELES , SINGAPORE, and TOKYO , ... announced that it has appointed Roger Crystal , ... most recently served in the Global Business Development Product ... "Roger,s experience in developing business strategy and ... valuable as we continue to partner with biotechnology and ...
(Date:7/28/2014)... 28, 2014  ANI Pharmaceuticals, Inc. (NASDAQ: ... release its second quarter and year-to-date 2014 financial results ... the U.S. financial markets. The earnings press release will ... Company,s website, www.anipharmaceuticals.com . Arthur ... Charlotte C. Arnold , Vice President and Chief ...
(Date:7/28/2014)...  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) ... Results and Highlights Conference CallWhen:Monday, August 4 at 10:30 ... on the Internet. Simply log onto our website listed ... live event, a replay of the webcast will be ... ABOUT ISIS PHARMACEUTICALS, INC. Isis is exploiting ...
Breaking Medicine Technology:ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development 2ANI Pharmaceuticals Schedules Conference Call for Second Quarter 2014 Financial Results 2Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call 2
... Nov. 12 Based on its recent analysis ... & Sullivan presents Fovia, Inc. with the 2009 ... Innovation of the Year. Fovia is being recognized ... platform that offers unrivaled image quality and uncompromised ...
... Corporation (Nasdaq: THOR ), a world leader in ... restore failing hearts, said today that it will webcast ... II Destination Therapy clinical trial that will be presented ... American Heart Association(AHA) Scientific Sessions 2009. , The event ...
Cached Medicine Technology:Frost & Sullivan Recognizes Fovia for its HDVR(R) Platform - A Disruptive Technology Breakthrough 2Frost & Sullivan Recognizes Fovia for its HDVR(R) Platform - A Disruptive Technology Breakthrough 3Frost & Sullivan Recognizes Fovia for its HDVR(R) Platform - A Disruptive Technology Breakthrough 4
... the challenge of,controlling costs while handling ... data,management is critical. INFINITY modular,patient monitors ... clinical information,wherever you are in the ... your job easier. You can monitor,your ...
... The biograph 6 offers ... improved disease diagnosis and treatment ... It delivers high-quality PET/CT whole ... 15 minutes. Our comprehensive suite ...
... offers the ultimate PET/CT performance ... treatment in oncology, neurology, and ... whole body scans in less ... suite of clinical applications offers ...
... Duo is a SmartBeam platform providing high-performance ... of the two most clinical sites - ... at a low radiation dose., ,The ... Windows, optimizes productivity and ensures consistant results. ...
Medicine Products: